1 – 5 of 31
- show: 5
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Local Treatment of Recurrent Renal Cell Carcinoma May Have a Significant Survival Effect Across All Risk-of-recurrence Groups
(
- Contribution to journal › Article
-
Mark
The need for core outcome sets in renal cancer clinical effectiveness research
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
A Systematic Review of Heterogeneity in Outcome Definition and Reporting in Localised Renal Cancer
(
- Contribution to journal › Scientific review
-
Mark
The 2022 Updated European Association of Urology Guidelines on the Use of Adjuvant Immune Checkpoint Inhibitor Therapy for Renal Cell Carcinoma
(
- Contribution to journal › Article
-
Mark
A Renewal of the TNM Staging System for Patients with Renal Cancer To Comply with Current Decision-making : Proposal from the European Association of Urology Guidelines Panel
(
- Contribution to journal › Debate/Note/Editorial